Comments

Telix Pharmaceuticals

Q: What sector and industry does Telix Pharmaceuticals (TLX) operate in?

Telix Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TLXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$15.40

0.634.28%

Pre-Market: Nov 20, 4:40 PM EDT

Telix Pharmaceuticals (TLX) Forecast

News Earnings Telix Pharmaceuticals (TLX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Telix Pharmaceuticals (NASDAQ:TLX) Stock Quotes, Forecast and News Summary

Telix Pharmaceuticals Stock (NASDAQ: TLX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 23.34K
Day Range	- - -
52 Wk Range	14.44 - 19.99
Market Cap	$4.93B
P/E Ratio	152.56
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	-

Recent News

Trans-Lux Not Successful in NYSE AMEX Delisting Appeal

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 23.34K
Day Range	- - -
52 Wk Range	14.44 - 19.99
Market Cap	$4.93B
P/E Ratio	152.56
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	-

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Telix Pharmaceuticals (TLX) stock?

You can purchase shares of Telix Pharmaceuticals (NASDAQ:TLX) through any online brokerage.

View our list of the best stock brokerages

Who are Telix Pharmaceuticals (TLX) competitors?

Other companies in Telix Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for Telix Pharmaceuticals (TLX) stock?

Telix Pharmaceuticals has a consensus price target of $21.00.

What is the current price for Telix Pharmaceuticals (TLX)?

The stock price for Telix Pharmaceuticals (NASDAQ: TLX) is $14.768 last updated November 21, 2024 at 12:51 PM EST.

Does Telix Pharmaceuticals (TLX) pay a dividend?

There are no upcoming dividends for Telix Pharmaceuticals.

When is Telix Pharmaceuticals (NASDAQ:TLX) reporting earnings?

Telix Pharmaceuticals does not have any upcoming earnings scheduled.

Is Telix Pharmaceuticals (TLX) going to split?

There is no upcoming split for Telix Pharmaceuticals.

What sector and industry does Telix Pharmaceuticals (TLX) operate in?

Telix Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.